SCHEMBL9834667

SCHEMBL9834667

CCn1c(-c2ccc(OC)c(OC)c2)cc(=Nc2c(C)cc(C)cc2C)n(C)c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 4/20 0.52
▸ PDE4A P27815 4/20 0.52
▸ PDE4D Q08499 4/20 0.52
▸ MAPT P10636 4/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ TDP1 Q9NUW8 3/20 0.52
▸ PDE4C Q08493 3/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ TSHR P16473 2/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ CYP2C9 P11712 2/20 0.52
▸ ABCC4 O15439 1/20 0.52
▸ ABCC5 O15440 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ THPO P40225 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ KMT2A Q03164 2/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9834662 1.00 PDE4B (0.52) PDE4BPDE4APDE4DMAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL10569610 0.99 TDP1 (0.52) PDE4BPDE4APDE4DMAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL10569609 0.99 TDP1 (0.52) PDE4BPDE4APDE4DMAPTSMN1; SMN2
SCHEMBL10566644 0.93 PDE4B (0.51) PDE4BPDE4APDE4DMAPTSMN1; SMN2
SCHEMBL10566643 0.93 PDE4B (0.51) PDE4BPDE4APDE4DMAPTSMN1; SMN2
SCHEMBL10566470 0.91 PDE4B (0.44) PDE4BPDE4APDE4DMAPTSMN1; SMN2
SCHEMBL10566474 0.91 PDE4B (0.44) PDE4BPDE4APDE4DMAPTSMN1; SMN2
SCHEMBL9615731 0.89 TSHR (0.41) PDE4BPDE4APDE4DMAPTSMN1; SMN2
SCHEMBL9615732 0.89 TSHR (0.41) PDE4BPDE4APDE4DMAPTSMN1; SMN2
SCHEMBL10567311 0.88 MAPT (0.48) PDE4BPDE4APDE4DMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 — — EP claimed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 — — US claimed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP claimed
JP-62126129-A — — None — — JP disclosed
EP-0200902-B1 DRUG CARRIER AND PHARMACEUTICAL PREPARATION COMPRISING IT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-10-02 — — EP disclosed
EP-0166564-B1 PYRIMIDONE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-01-31 — — EP disclosed
US-4824851-A Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-25 — — US disclosed
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 — — EP disclosed
US-4746664-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-24 — — US disclosed
US-4690822-A CARRIER MIXTURE OF AQUEOUS POLYMER AND LIQUID OIL FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-09-01 — — US disclosed
JP-S62126129-A ANTIALLERGIC DRUG FUJISAWA PHARMACEUT CO LTD 1987-06-08 — — JP disclosed
US-4649142-A 3,4-dihydro-1,3-disubstituted-6-(substituted phenylimino)-2(1H)-pyrimidinone useful as cardiotonic agent and anti-allergic agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-03-10 — — US disclosed
EP-0200902-A2 Drug carrier and pharmaceutical preparation comprising it FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-11-12 — — EP disclosed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 — — US disclosed
EP-0166564-A2 Pyrimidone derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 — — EP disclosed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
Send feedback